C8B
Complement component C8 beta chain
Also known as: CO8B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P07358
- Gene
- C8B
- Ensembl
- ENSG00000021852
- Chromosome
- 1
- Canonical length
- 591 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes one of the three subunits of the complement component 8 (C8) protein. C8 is composed of equimolar amounts of alpha, beta and gamma subunits, which are encoded by three separate genes. C8 is one component of the membrane attack complex, which mediates cell lysis, and it initiates membrane penetration of the complex. This protein mediates the interaction of C8 with the C5b-7 membrane attack complex precursor. In humans deficiency of this protein is associated with increased risk of meningococcal infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]
Canonical amino-acid sequenceUniProt
591 residues, UniProt reviewed canonical sequence.
>P07358|C8B
1 MKNSRTWAWR APVELFLLCA ALGCLSLPGS RGERPHSFGS NAVNKSFAKS RQMRSVDVTL
61 MPIDCELSSW SSWTTCDPCQ KKRYRYAYLL QPSQFHGEPC NFSDKEVEDC VTNRPCGSQV
121 RCEGFVCAQT GRCVNRRLLC NGDNDCGDQS DEANCRRIYK KCQHEMDQYW GIGSLASGIN
181 LFTNSFEGPV LDHRYYAGGC SPHYILNTRF RKPYNVESYT PQTQGKYEFI LKEYESYSDF
241 ERNVTEKMAS KSGFSFGFKI PGIFELGISS QSDRGKHYIR RTKRFSHTKS VFLHARSDLE
301 VAHYKLKPRS LMLHYEFLQR VKRLPLEYSY GEYRDLFRDF GTHYITEAVL GGIYEYTLVM
361 NKEAMERGDY TLNNVHACAK NDFKIGGAIE EVYVSLGVSV GKCRGILNEI KDRNKRDTMV
421 EDLVVLVRGG ASEHITTLAY QELPTADLMQ EWGDAVQYNP AIIKVKVEPL YELVTATDFA
481 YSSTVRQNMK QALEEFQKEV SSCHCAPCQG NGVPVLKGSR CDCICPVGSQ GLACEVSYRK
541 NTPIDGKWNC WSNWSSCSGR RKTRQRQCNN PPPQNGGSPC SGPASETLDC SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C8B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 608 nTPM
Expression across tissuesHPA
Tissue
- liver: 608 nTPM
- lung: 4.8 nTPM
- gallbladder: 0.3 nTPM
- testis: 0.3 nTPM
- salivary gland: 0.2 nTPM
- spleen: 0.2 nTPM
Single-cell type
- hepatocytes: 351 nCPM
- cholangiocytes: 20 nCPM
- late spermatids: 18 nCPM
- early spermatids: 9.6 nCPM
- respiratory ciliated cells: 5.4 nCPM
- endometrial ciliated cells: 2.6 nCPM
Immune cell
- basophil: 2.3 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about C8B.
Disease | AllUniProt
Conditions C8B is implicated in, by any mechanism.
- Complement component 8 deficiency, 2 (C8D2) MIM:613789
Disease | GeneticClinVar
42 pathogenic / likely-pathogenic of 443 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Type II complement component 8 deficiency
- C8B-related disorder
- Complement component 6 deficiency
- Cholangiocarcinoma
Disease | ImmuneIEDB
Conditions an epitope on C8B was assayed in.
- rheumatoid arthritis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.33
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.74
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- complement activation
- complement activation, alternative pathway
- complement activation, classical pathway
- complement activation, GZMK pathway
- immune response
- killing of cells of another organism
- positive regulation of immune response
- transmembrane transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thrombospondin type-1 (TSP1) repeat
- Membrane attack complex component/perforin/complement C9
- Low-density lipoprotein (LDL) receptor class A repeat
- Membrane attack complex component/perforin domain, conserved site
- Membrane attack complex component/perforin (MACPF) domain
- Low-density lipoprotein (LDL) receptor class A, conserved site
- LDL receptor-like superfamily
- Thrombospondin type-1 repeat superfamily
- Complement components C8A/B/C6, EGF-like domain
- Low-density lipoprotein receptor domain class A
- Thrombospondin type 1 domain
- MAC/Perforin domain
- Complement components C8A/B/C6, EGF-like domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C8B as an antibody target. Whether an autoantibody or antibody against C8B could matter depends on whether native C8B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C8B is annotated at the cell surface, where native C8B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label C8B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...